William Lazonick, professor emeritus of economics at University of Massachusetts, is co-founder and president of the Academic-Industry Research Network, a 501(c)(3) non-profit research organization, based in Cambridge, Massachusetts. He is an Open Society Fellow and a Canadian Institute for Advanced Research Fellow.Over the past decade, the Institute for New Economic Thinking has funded a number of his research projects.

He has professorial affiliations with SOAS University of London and Institut Mines-Télécom in Paris. Previously, Lazonick was assistant and associate professor of economics at Harvard University, professor of economics at Barnard College of Columbia University, and distinguished research professor at INSEAD in France. Lazonick earned his B.Com. at the University of Toronto, M.Sc. in Economics at London School of Economics, and Ph.D. in Economics at Harvard University. He holds honorary doctorates from Uppsala University and the University of Ljubljana.

His research focuses on the social conditions of innovation and economic development in advanced and emerging economies. His book Sustainable Prosperity in the New Economy? Business Organization and High-Tech Employment in the United States (Upjohn Institute 2009) won the 2010 Schumpeter Prize. He has twice—in 1983 and 2010—had the award from Harvard Business School for best article of the year in Business History Review. In 2014, he received the HBR McKinsey Award for outstanding article in Harvard Business Review for “Profits Without Prosperity: Stock Buybacks Manipulate the Market and Leave Most Americans Worse Off.” In January 2020, Oxford University Press published his book, co-authored with Jang-Sup Shin, Predatory Value Extraction: How the Looting of the Business Corporation Became the U.S. Norm and How Sustainable Prosperity Can Be Restored.

By this expert

Is the Most Unproductive Firm the Foundation of the Most Efficient Economy? Penrosian Learning Confronts the Neoclassical Fallacy

Paper Working Paper Series | | Jan 2020

To get beyond the neoclassical fallacy, economists have to stop relying on constrained-optimization methodology

Financialization of the U.S. Pharmaceutical Industry

Article | Dec 2, 2019

Pharmaceutical drugs are often a matter of life or death. It should be a prime objective of government policy to rid the industry of financialization.

Don't “Buyback” Fair Labor Standards

Article | Feb 20, 2019

We need to ban stock buybacks, while building a movement for basic economic rights

​Apple’s “Capital Return Program”: Where Are the Patient Capitalists?

Article | Nov 13, 2018

Instead of rewarding the taxpayers and employees who actually create value for the tech giant, Apple is doling out massive stock buybacks

Featuring this expert

William Lazonick in the New York Times on Pharma CEO Pay

News Feb 26, 2019

INET grantee William Lazonick’s research on drug pricing is featured in a New York Times op-ed

Bill Lazonick Research in New York Times

News Nov 19, 2018

William Lazonick’s INET research is featured in his New York Times op-ed

American Prospect Features INET Pharma Research

News Aug 27, 2018

The American Prospect highlights William Lazonick’s INET paper on US Pharma’s Financialized Business Model.

Washington Post Features Bill Lazonick's Research

News Aug 16, 2018

The Washington Post cites William Lazonick’s INET paper on shareholder value